When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...

Prostate cancer is the most common cancer diagnosis in men, accounting for 30% of male cancers in 2025, and is the second ...

Findings are in line with documented impacts on screening, diagnosis, and treatment ...

A new study reveals that cancer patients diagnosed during the early COVID-19 pandemic had worse short-term survival rates.

Patients diagnosed with cancer in the U.S. during the first two years of the COVID-19 pandemic had significantly lower one-year cancer survival rates, leading to an estimated 17,390 more deaths than ...

The latest data point to improvements for many cancer types and a continued decline in overall cancer mortality.

A separate 2024 study in the Journal of the National Cancer Institute documented a dip in one-year survival for patients ...

A Registrational Phase 2 clinical trial has been initiated in Japan for patients with PSMA-positive metastatic castration-resistant prostate ...

A retrospective real-world study supports apalutamide as a standard of care treatment for patients with mCSPC.

Colorectal cancer is often spoken of as a single disease, but it actually refers to two related cancers: colon cancer and rectal cancer. The latter was recently revealed as the reason we lost the ...

The latest American Cancer Society report shows a 34% drop in cancer mortality since 1991, but reveals a worrying increase in ...

Bo Jackson, the legendary athlete who starred in both the NFL and MLB, recently shared an update about his prostate cancer ...